These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26374813)

  • 1. Response to "Level 2 Observational Studies: A Practical Alternative to Randomized Trials in Plastic Surgery".
    Eaves FF; Thoma A
    Aesthet Surg J; 2016 Feb; 36(2):NP89-91. PubMed ID: 26374813
    [No Abstract]   [Full Text] [Related]  

  • 2. Level 2 Observational Studies: A Practical Alternative to Randomized Trials in Plastic Surgery.
    Swanson E
    Aesthet Surg J; 2016 Feb; 36(2):NP87-8. PubMed ID: 26374809
    [No Abstract]   [Full Text] [Related]  

  • 3. Some Random(ized) Thoughts.
    Thoma A; Eaves FF
    Aesthet Surg J; 2015 Jul; 35(5):627-9. PubMed ID: 26116744
    [No Abstract]   [Full Text] [Related]  

  • 4. Sebum Production Alteration after Botulinum Toxin Type A Injections for the Treatment of Forehead Rhytides: A Prospective Randomized Double-Blind Dose-Comparative Clinical Investigation.
    Min P; Xi W; Grassetti L; Trisliana Perdanasari A; Torresetti M; Feng S; Su W; Pu Z; Zhang Y; Han S; Zhang YX; Di Benedetto G; Lazzeri D
    Aesthet Surg J; 2015 Jul; 35(5):600-10. PubMed ID: 25825422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head-to-head studies of botulinum toxin A in aesthetic medicine: which evidence is good enough?
    Rzany B; Nast A
    J Am Acad Dermatol; 2007 Jun; 56(6):1066-7. PubMed ID: 17504724
    [No Abstract]   [Full Text] [Related]  

  • 6. A practical guide to achieving successful outcomes with botulinum toxin type A. IMCAS Meeting, Paris 2002.
    Ascher B; Lowe N; Flynn TC; Kane MA; Ney R; Sylvestre G
    J Cosmet Laser Ther; 2002; 4 Suppl 1():1-6. PubMed ID: 16210204
    [No Abstract]   [Full Text] [Related]  

  • 7. Commentary: Efficacy and safety of a novel botulinum toxin topical gel.
    West TB
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2119-20. PubMed ID: 21244565
    [No Abstract]   [Full Text] [Related]  

  • 8. A new technique for the application of botulinum toxin in short and tall foreheads.
    Ozsoy Z; Genc B; Gözü A
    Plast Reconstr Surg; 2005 Apr; 115(5):1439-41. PubMed ID: 15809628
    [No Abstract]   [Full Text] [Related]  

  • 9. Commentary: Revisiting the data: mild resting glabellar lines improve with onabotulinumtoxinA.
    Contreras ME; Cohen JL
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2172-4. PubMed ID: 21244567
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary on Evolution of Facial Aesthetic Treatment Over Five or More Years.
    Jagdeo J
    Dermatol Surg; 2015 Jul; 41(7):848-9. PubMed ID: 26035045
    [No Abstract]   [Full Text] [Related]  

  • 11. Facial rejuvenation after intradermal botulinum toxin: is it really the botulinum toxin or is it the pricks?
    Kapoor R; Shome D; Jain V; Dikshit R
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2098-105. PubMed ID: 21134041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social implications of hyperdynamic facial lines and patient satisfaction outcomes.
    Cox SE; Finn JC
    Int Ophthalmol Clin; 2005; 45(3):13-24. PubMed ID: 15970763
    [No Abstract]   [Full Text] [Related]  

  • 13. Intraoperative injection of botulinum toxin A into the orbicularis oculi muscle for the treatment of crow's feet.
    Guerrissi JO
    Plast Reconstr Surg; 2003 Oct; 112(5 Suppl):161S-163S. PubMed ID: 14504499
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety evaluation of a novel botulinum toxin topical gel for the treatment of moderate to severe lateral canthal lines.
    Brandt F
    Dermatol Surg; 2011 Jul; 37(7):1060. PubMed ID: 21711409
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective botulinum neurotoxin application: the interaction of evolution, biology, and culture in diagnosing and healing the miscues of human facial expression.
    Khan JA
    Int Ophthalmol Clin; 2005; 45(3):1-11. PubMed ID: 15970762
    [No Abstract]   [Full Text] [Related]  

  • 16. "M" marks the spot: Update on treatment guidelines for botulinum toxin type A for the periocular area.
    Matarasso SL; Matarasso A
    Plast Reconstr Surg; 2003 Oct; 112(5):1470-2. PubMed ID: 14504535
    [No Abstract]   [Full Text] [Related]  

  • 17. Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines.
    Sattler G; Callander MJ; Grablowitz D; Walker T; Bee EK; Rzany B; Flynn TC; Carruthers A
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2146-54. PubMed ID: 21134045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, randomized, placebo-controlled health-outcomes survey of the effect of botulinum toxin type a injections on quality of life and self-esteem.
    Dayan SH; Arkins JP; Patel AB; Gal TJ
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2088-97. PubMed ID: 21070456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin cooling provides minimal relief of patient discomfort during periocular botulinum toxin type A injection.
    Beer KR; Wilson F
    Dermatol Surg; 2011 Jun; 37(6):870-2. PubMed ID: 21605254
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of two botulinum toxin type A preparations for treating crow's feet: a split-face, double-blind, proof-of-concept study.
    Prager W; Wissmüller E; Kollhorst B; Williams S; Zschocke I
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2155-60. PubMed ID: 21134046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.